Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatotropin in Spinal Muscular Atrophy Type II and III
NCT00533221Phase 2Completed
- Sponsor
- University Hospital Freiburg
- Start
- Oct 2007
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of somatotropin in Spinal Muscular Atrophy Type II, spinal muscular atrophy type 3 (SMA3), sponsored by University Hospital Freiburg. Started Oct 2007; status: completed.
02
Drugs
somatotropin
03
Conditions
Spinal Muscular Atrophy Type IIspinal muscular atrophy type 3 (SMA3)
Beyond the preview
Go deeper on NCT00533221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533221.